DK0764447T3 - Fremstilling af viralt inaktiveret intravenøst injicerbart immunserumglobulin - Google Patents

Fremstilling af viralt inaktiveret intravenøst injicerbart immunserumglobulin

Info

Publication number
DK0764447T3
DK0764447T3 DK96114439T DK96114439T DK0764447T3 DK 0764447 T3 DK0764447 T3 DK 0764447T3 DK 96114439 T DK96114439 T DK 96114439T DK 96114439 T DK96114439 T DK 96114439T DK 0764447 T3 DK0764447 T3 DK 0764447T3
Authority
DK
Denmark
Prior art keywords
solution
preparation
immune serum
serum globulin
virally inactivated
Prior art date
Application number
DK96114439T
Other languages
Danish (da)
English (en)
Inventor
William R Alonso
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24120836&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0764447(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of DK0764447T3 publication Critical patent/DK0764447T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • A61L2/0088—Liquid substances
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
DK96114439T 1995-09-22 1996-09-10 Fremstilling af viralt inaktiveret intravenøst injicerbart immunserumglobulin DK0764447T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/532,211 US6686191B1 (en) 1995-09-22 1995-09-22 Preparation of virally inactivated intravenously injectable immune serum globulin

Publications (1)

Publication Number Publication Date
DK0764447T3 true DK0764447T3 (da) 2004-05-03

Family

ID=24120836

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96114439T DK0764447T3 (da) 1995-09-22 1996-09-10 Fremstilling af viralt inaktiveret intravenøst injicerbart immunserumglobulin

Country Status (10)

Country Link
US (1) US6686191B1 (de)
EP (2) EP1356829A3 (de)
JP (1) JP4036494B2 (de)
AT (1) ATE257016T1 (de)
AU (1) AU709608B2 (de)
CA (1) CA2185859C (de)
DE (1) DE69631229T2 (de)
DK (1) DK0764447T3 (de)
ES (1) ES2213760T3 (de)
PT (1) PT764447E (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0973549A2 (de) * 1997-04-07 2000-01-26 Cangene Corporation Intravenöse immunglobulinzusammensetzungen die ein nichtionisches oberfläche-aktives agens enthält mit verbesserten pharmakokinetischen eigenschaften
CA2285935C (en) 1997-04-08 2011-01-18 Baxter Aktiengesellschaft An immunotolerant prothrombin complex preparation
AT405608B (de) * 1997-04-08 1999-10-25 Immuno Ag Verfahren zur inaktivierung von pathogenen, insbesondere von viren, in einem biologischen material
WO2001013423A1 (fr) * 1999-08-10 2001-02-22 Ibiden Co., Ltd. Plaque ceramique pour dispositif de production de semi-conducteurs
US6875432B2 (en) 2000-10-12 2005-04-05 Genentech, Inc. Reduced-viscosity concentrated protein formulations
US8703126B2 (en) 2000-10-12 2014-04-22 Genentech, Inc. Reduced-viscosity concentrated protein formulations
KR100791502B1 (ko) * 2006-09-29 2008-01-03 한스바이오메드 주식회사 바이러스 불활화된 무세포 인체 이식재 생산방법
EP2077118A1 (de) * 2008-01-07 2009-07-08 Gwo Rei Biomedical Technology Corp. Gerinnungsfähiges Konzentrat von Plättchenwachstumsfaktoren und Herstellungsverfahren dafür
RU2011140498A (ru) 2009-03-06 2013-04-20 Дженентек, Инк. Препарат антител
KR101807894B1 (ko) 2010-03-01 2017-12-12 바이엘 헬스케어 엘엘씨 조직 인자 경로 억제제 (ｔｆｐｉ)에 대한 최적화된 모노클로날 항체
CN102357259A (zh) 2011-07-28 2012-02-22 王珊珊 一种生物蛋白海绵及其制备方法
WO2014004103A1 (en) 2012-06-29 2014-01-03 Emd Millipore Corporation Methods for inactivating viruses during a protein purification process
US8613919B1 (en) 2012-08-31 2013-12-24 Bayer Healthcare, Llc High concentration antibody and protein formulations
US9592297B2 (en) 2012-08-31 2017-03-14 Bayer Healthcare Llc Antibody and protein formulations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4396608A (en) * 1981-08-24 1983-08-02 Cutter Laboratories Intravenously injectable immune serum globulin
US4540573A (en) * 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
US4762714A (en) * 1986-04-08 1988-08-09 Miles Laboratories, Inc. Preparation of retrovirus-free immunoglobulins
GB8628104D0 (en) * 1986-11-25 1986-12-31 Connaught Lab Pasteurization of immunoglobin solutions
ATE174383T1 (de) * 1991-07-05 1998-12-15 Bayer Ag Verwendung von tri-n-butylphosphat bei niedrigem ph in lösungen von biologisch aktiven proteinen für eine verbesserte viruzide wirkung

Also Published As

Publication number Publication date
DE69631229D1 (de) 2004-02-05
ATE257016T1 (de) 2004-01-15
EP1356829A2 (de) 2003-10-29
EP0764447B1 (de) 2004-01-02
DE69631229T2 (de) 2004-12-02
ES2213760T3 (es) 2004-09-01
CA2185859C (en) 2011-04-19
US6686191B1 (en) 2004-02-03
JP4036494B2 (ja) 2008-01-23
EP1356829A3 (de) 2003-12-17
AU709608B2 (en) 1999-09-02
EP0764447A2 (de) 1997-03-26
JPH09124507A (ja) 1997-05-13
PT764447E (pt) 2004-04-30
EP0764447A3 (de) 1997-07-30
CA2185859A1 (en) 1997-03-23
AU6569096A (en) 1997-03-27

Similar Documents

Publication Publication Date Title
DK0764447T3 (da) Fremstilling af viralt inaktiveret intravenøst injicerbart immunserumglobulin
US4764369A (en) Undenatured virus-free biologically active protein derivatives
ATE267214T1 (de) Chromatographieverfahren für reinigung von igg mit hoher ausbeute und virusinaktivierung
ATE149355T1 (de) Verfahren zur inaktivierung von prionen
ES8202584A1 (es) Un procedimiento para la preparacion de una vacuna viral vi-va estabilizada y mejorada.
US4820805A (en) Undenatured virus-free trialkyl phosphate treated biologically active protein derivatives
JPS6485929A (en) Sterilization for immnogloblin solution
DE68906735D1 (de) Pharmazeutische zubereitung zur behandlung von viruskrankheiten mit leber-extrakt.
GB1488774A (en) Hepatitis b antigen and method of producing it
CA2063303A1 (en) Preparation of virus-free immunoglobulins
DK573587A (da) Fremgangsmaade til fremstilling af en faktor viii (ahf)-holdig fraktion
IE860315L (en) Detecting htlv-iii neutralising antibodies
NZ334885A (en) Method for producing an igm preparation for intravenous administration
EP0523406B1 (de) Verwendung von Tri-n-Butylphosphat bei niedrigem pH in Lösungen von biologisch aktiven Proteinen für eine verbesserte viruzide Wirkung
JPS63216479A (ja) エンベロープ含有ウイルスの不活化法
CA1207662A (en) Hepatitis b and non-a-non-b-safe biological products
ATE285255T1 (de) Verfahren zur inaktivierung von viren
Horowitz et al. Elimination of disease-transmitting enveloped viruses from human blood plasma and mammalian cell culture products: Assurance of virus safety of biological products.
DK0457035T3 (da) Fremgangsmåde til inaktivering af den biologiske aktivitet af DNA
Laurent et al. Characterisation of the interferon-mediated protein kinase by polyclonal antibodies
Ozaki Growth of poliovirus type 1 in a non-primate cell line (PS cell) after artificial adsorption
SU780261A1 (ru) Способ определени термолабильных вирусотропных ингибиторов
RU94038847A (ru) Способ получения нитерферона
EP0244146A3 (de) Probe zum Nachweis von Hepatitis-A-Viren
PAYNE STUDIES ON ACUTE AND LATENT HERPES SIMPLEX VIRUS TYPE 1 INFECTIONS AND THE INFLUENCE OF SERUM IMMUNOGLOBULINS.